BioHarvest Sciences Inc. Common Stock (BHST) has a negative trailing P/E of -7.1, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. The forward P/E of 8.2 based on analyst estimates suggests a return to profitability is expected. Trailing earnings yield is -14.03%, forward earnings yield 12.18%. PEG 0.09 (Peter Lynch undervalued ≤1.0).
Criteria proven by this page:
Overall SharesGrow Score: 53/100 with 2/7 criteria passed.
| Year | P/E (TTM) | PEG Ratio | P/B Ratio | P/S Ratio | Dividend Yield |
|---|---|---|---|---|---|
| 2017 | 0.0 | 0.00 | -25.62 | 0.00 | - |
| 2018 | 0.0 | 0.00 | 8.21 | 0.00 | - |
| 2019 | 0.0 | 0.00 | 2.20 | 0.00 | - |
| 2019 | -2.8 | 0.11 | -0.48 | 67.66 | - |
| 2020 | -7.4 | 0.12 | -21.16 | 122.65 | - |
| 2021 | -6.3 | 0.00 | 21.80 | 29.61 | - |
| 2022 | -5.8 | 0.00 | -11.01 | 11.87 | - |
| 2023 | -5.4 | -0.16 | -4.56 | 5.34 | - |
| 2024 | -7.8 | 0.55 | 75.25 | 3.97 | - |
| 2025 | -8.6 | 0.34 | 3.75 | 2.77 | - |
| Year | EPS (Diluted) | Revenue | Net Income | Net Margin |
|---|---|---|---|---|
| 2016 | $-0.19 | $0.00 | $0.00 | - |
| 2017 | $-0.21 | $0.00 | $0.00 | - |
| 2018 | $-2.34 | $0.00 | $0.00 | - |
| 2019 | $-1.75 | $218K | $-5.31M | -2435.8% |
| 2020 | $-0.70 | $396K | $-6.58M | -1662.6% |
| 2021 | $-0.70 | $2.1M | $-9.83M | -467.5% |
| 2022 | $-0.70 | $5.5M | $-11.24M | -204.4% |
| 2023 | $-0.93 | $12.67M | $-12.56M | -99.1% |
| 2024 | $-0.80 | $25.19M | $-12.91M | -51.3% |
| 2025 | $-0.60 | $34.51M | $-11.14M | -32.3% |
| Year | EPS (Avg) | EPS Range | Revenue (Avg) | Revenue Range | Analysts |
|---|---|---|---|---|---|
| 2026 | $-0.14 | $-0.14 – $-0.13 | $48.03M | $47.39M – $48.66M | 2 |
| 2027 | $0.12 | $0.09 – $0.15 | $65.34M | $65.21M – $65.48M | 3 |
| 2028 | $0.60 | $0.56 – $0.63 | $98.02M | $93.44M – $101.55M | 1 |
| 2029 | $1.00 | $0.94 – $1.05 | $134.99M | $128.69M – $139.85M | 1 |
